LCP-Tacrolimus Requires a Similar Empiric Dose Adjustment to Immediate-Release Tacrolimus When Given Concomitantly With Letermovir for Cytomegalovirus Primary Prophylaxis

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients

(2023) Ajit P. Limaye et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Letermovir Prophylaxis in Solid Organ Transplant ‐ Assessing CMV Breakthrough and Tacrolimus Drug Interaction

(2021) Ryan J Winstead et al.   Transplant Infectious Disease

The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients

(2021) Margaret R. Jorgenson et al.   Transplant Infectious Disease

PBPK Modeling Strategy for Predicting Complex Drug Interactions of Letermovir as a Perpetrator in Support of Product Labeling

(2018) Ying-Hong Wang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

SP740ASSESSMENT OF THE EFFECT OF DRUG FORMULATION ON THE EXTENT OF THE PHARMACOKINETIC INTERACTION BETWEEN VORICONAZOLE AND TACROLIMUS

(2018) Christian Ott et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study

(2016) S. Tremblay et al.   AMERICAN JOURNAL OF TRANSPLANTATION